News
In this video, Raj Chovatiya, MD, PhD, discusses the latest findings on the use of topical roflumilast in patients with ...
Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.
15h
Clinical Trials Arena on MSNAlumis concludes enrolment in Phase III programme of plaque psoriasis therapyThe programme comprises two Phase III trials, ONWARD1 and ONWARD2, and an optional long-term extension trial, ONWARD3.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results